cells

This call is currently closed

Introduction

This call is for bold, innovative research that has the potential to impact the way prostate cancer is diagnosed, treated or prevented. This scheme will fund fundamental and clinical research, and all stages in between; however, research at all stages will be expected to have a focus on eventual benefit to men. Applicants will be expected to set out a logical and realistic path of work that will need to happen at the end of the award in order to deliver that benefit to men.

We will also consider applications that bring innovative ideas from other cancer types and other diseases to be tested or translated for prostate cancer. We encourage applicants to build teams that include experts from other disciplines and other countries where that will improve the project.

All proposals must align with our research strategy and clearly demonstrate the innovative nature of the research and how it will lead to improved health and well-being for men affected by, or at high risk of, prostate cancer.

Eligibility and award

  • Average project length is one to five years. Projects that are shorter or longer than one to five years are still eligible, although you should discuss this with the Research team at Prostate Cancer UK before applying.
  • There isn’t a maximum award cap. Please note that value for money will be a consideration in making final funding decisions, and so we would advise applicants to ensure that the amount they are requesting is a realistic reflection of what is needed.
  • Research Innovation Awards must be held at a UK based University, NHS site or other recognised higher research institution.
  • All awards made will be in line with our terms and conditions (please note that these terms may be subject to change). 
Finance Eligibility Guidance

Application process and assessment

There is a two-stage application process whereby applicants initially submit an Expression of Interest and if shortlisted, are requested to submit a more detailed Second Stage application. Applicants should ensure they download and carefully read the guidance notes before submitting their proposal.

2018 RIA EOI Guidance 2018 RIA Stage 2 Guidance

 

1: Expression of Interest (EOI) Stage

  • The round will close for application at 12pm (noon) Monday 17 September 2018.
  • Applications are firstly validated by the Research Team at Prostate Cancer UK to eliminate those which do not meet the basic eligibility criteria for this call.
  • The remaining applications will then be considered by our Research Advisory Committee, who will decide which proposals should be shortlisted to the Second Stage.

2: Second Stage (for shortlisted applicants)

  • Shortlisted applicants will be issued with a Second Stage application form the week commencing 12 November 2018.
  • Applications will be peer reviewed by at least three independent referees (in accordance with AMRC guidelines).
  • Applicants may then respond to the anonymised referees’ comments the week commencing 4 March 2019.
  • Proposals are further reviewed for the final funding decision by our Research Advisory Committee.

Once the final funding decisions have been confirmed, applicants will be informed of the outcome by email in May 2019.

Application success rates

  • 2017/18: 15% success rate, 54 Expression of Interest applications received.
  • 2016/17: 12% success rate, 58 Expression of Interest applications received.
  • 2015/16: 13% success rate, 64 Expression of Interest applications received.

Funded Research Innovation Awards

You can view our current and previously funded Research Innovation Awards here.

Contact

If you have any questions or would like to discuss an application with the Research team, please e-mail research@prostatecanceruk.org or call 020 3310 7258.